<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01950975</url>
  </required_header>
  <id_info>
    <org_study_id>VABRES PHRC N 2010</org_study_id>
    <nct_id>NCT01950975</nct_id>
  </id_info>
  <brief_title>Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.</brief_title>
  <acronym>MOSA√èQUE</acronym>
  <official_title>Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism. National Multicentre Descriptive Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal result expected is the discovery of inframicroscopic chromosomal rearrangements
      in regions of the genome not yet known to be involved, or mutations in known candidate genes;

      The identification of such a mosaic rearrangement in an affected infant would lead to
      improved genetic counselling. Indeed, as this mosaicism is a consequence of a genetic event
      occurring at an early stage of embryogenesis, it would be possible to confirm the sporadic
      nature of the observed disorder and therefore to predict a very low or even negligible risk
      of recurrence for the couple concerned. For the affected infant, the risk for his/her own
      offspring will be assessed according to the nature of the genetic anomaly discovered. For
      medical practice, investigators hope that this study will lead to a clearer definition of the
      screening modalities for mosaicism in the disorders concerned. In particular, they hope to
      determine whether or not it is possible to dispense with a skin biopsy, which is more
      invasive than a blood sample.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or not of inframicroscopic chromosomal rearrangements</measure>
    <time_frame>baselines</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of detection of a chromosomal anomaly</measure>
    <time_frame>baselines</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Malformations With Skin Manifestations Suggesting Mosaicism</condition>
  <arm_group>
    <arm_group_label>Parents</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>2 parents of child</description>
  </arm_group>
  <arm_group>
    <arm_group_label>infant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Peripheral blood samples in EDTA tubes</intervention_name>
    <arm_group_label>Parents</arm_group_label>
    <arm_group_label>infant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Skin biopsies</intervention_name>
    <arm_group_label>infant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons who have provided written informed consent

          -  Lower age limit: infant born at more than 37 WA

          -  Sporadic disorder

          -  Patients presenting at least two skin criteria, or one skin criterion and one non-skin
             criterion

          -  Skin criteria: 1- extensive epidermal or sebaceous naevus, 2- Extensive &quot;segmental&quot;
             haemangioma, 3- Flat angioma or extensive complex vascular malformation, 4-Pigmentary
             disorders with patterns suggesting mosaicism (Blaschko lines)

          -  Non-skin criteria: Cerebral, ocular, cardiac or genito-urinary malformation,
             asymmetric body, segmental hypertrophy of a limb, spinal dysraphism (only when
             associated with haemangioma)

        Exclusion Criteria:

          -  Persons not covered by the national health insurance scheme

          -  Mendelian disorders: CM-AVM syndrome, glomangiomatosis, Cowden or Bannayan syndrome,
             type 1 neurofibromatosis, incontinentia pigmenti, CHILD syndrome, Happle-type
             chondrodysplasia punctata

          -  Mendelian mosaic disorders: epidermal or epidermolytic, comedo or dyskeratotic nevus.

          -  Family history of one of these disorders

          -  Suspicion or an autosomal dominant disease

          -  Patient and/or parent under guardianship or ward of court
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>37 Weeks</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre VABRES</last_name>
    <phone>03.80.29.33. 36</phone>
    <email>pierre.vabres@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre VABRES</last_name>
      <phone>03.80.29.33. 36</phone>
      <email>pierre.vabres@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2013</study_first_submitted>
  <study_first_submitted_qc>September 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2013</study_first_posted>
  <last_update_submitted>September 23, 2013</last_update_submitted>
  <last_update_submitted_qc>September 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Skin Manifestations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

